Vedanta Biosciences is a pioneering brand that combines medicine and ecology to develop transformative therapies. They focus on the human microbiome, which is home to trillions of microbes that play a crucial role in our health. By leveraging insights from microbial ecology, mucosal immunology, and human interventional studies, Vedanta Biosciences designs medicines based on consortia of human commensal bacteria to treat various diseases.

Their drugs are made of defined bacterial consortia that are carefully selected for optimal therapeutic activity. With a state-of-the-art manufacturing facility, Vedanta Biosciences is the first to achieve commercial-scale production of drug candidates based on defined bacterial consortia. They have also secured foundational patents that cover bacterial consortia drugs containing Clostridium bacteria, a prevalent group in the gut.

Founded by scientific leaders in immunology and microbiome research, Vedanta Biosciences is at the forefront of groundbreaking science in microbial ecology and immunology